glp-1 receptor agonists in idiopathic intracranial hypertension glp 1 and Excited to share our study @JAMANeuro RA therapy for GLP-1 receptor agonists may improve
Description
Do not use this drug if you or a family member has had: Medullary Thyroid Carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) FDA Adverse Event Reporting To report side effects, visit www.fda.gov/medwatch or call 1-800-FDA-1088

Risk of thyroid tumors with GLP-1 receptor agonists: a retrospective cohort study

Source: Tata 1mg

Here we report a unimolecular compound composed of a small-molecule antagonist and a peptide agonist for obesity treatment
doi: 10.3390/ijms25105059

The recent surge in popularity of medications like Wegovy (semaglutide) and Zepbound (tirzepatide) (tirzepatide) has changed the landscape of medical weight loss
